Skip to main content

EraGen's Hrusovsky Plays on Zeal for Business World


It’s lucky for Madison, Wisconsin’s bioinformatics and genotyping firm EraGen Biosciences that new president and CEO Irene Hrusovsky, a self-proclaimed health nut who’s always been interested in genetics, has a thing for commercialization. A pediatrician by training, she got her industry start at Abbott Laboratories almost 25 years ago. The mentality there was to commercialize new technology or a new business as soon as possible: “When it looked feasible, they would fund a venture,” she says. The practice allowed Hrusovsky to cut her teeth launching new business units. “That was my foray into general management. It really fueled my love for commercialization.”

She eventually moved to GlaxoSmithKline as the vice president of general medicine and medical marketing strategy, but what she wound up working on was a strategic redesign of the company (then Glaxo Wellcome) prior to its merger. Before leaving, she designed and launched a new business unit as well.

Hrusovsky predicts that her strategy background will come in handy at EraGen, where her role is to take the science and technology that attracted her to the company and turn them into the basis of a successful business. “Like every other company, we really need dollars,” she says. “We’re out now looking at our second round of funding” — which she hopes will hit $15 million or $20 million. “We have got to build a commercial arm.” Exactly what she’s looking forward to.

— Meredith Salisbury


The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.